ASHLAND, OR / ACCESS Newswire / July 15, 2025 / Satya Therapeutics, a leading psilocybin service center and manufacturer in Oregon, has announced a series of significant achievements that reinforce its leadership in the state's rapidly expanding psychedelic wellness industry.
Manufacturing License Renewal
Renewed License: Satya Therapeutics successfully renewed its Oregon Psilocybin Manufacturing License on June 30 with the Oregon Health Authority (OHA).
Continued Innovation: The renewal allows Satya to continue producing its proprietary psilocybin mushroom blends, with specific formulas designed for clients on SSRIs and antipsychotics.
Affordable Access: Commitment to affordable psilocybin products is highlighted by a current average price of $1.00 per milligram for service center partners. Plans for a forthcoming psilocybin cooperative aim to lower prices to $0.75 per mg or less, broadening access across the state.
Client Growth and Service Accessibility
Client Milestones: Since its opening in July 2023, Satya expects to serve its 1,100th client this July.
2025 Growth: The first half of 2025 saw 286 clients, signaling robust, ongoing demand.
Affordable Journeys: Individual, all-inclusive psilocybin sessions are available for $1,000-$1,250, supporting a diverse clientele seeking transformative care.
Quality and Value: While not the lowest-priced option in Oregon, Satya emphasizes value through professional facilitation, premium mushrooms, a safe environment, and unlimited preparation and integration sessions at no extra cost.
Client Feedback: The center boasts 111 five-star Google reviews, reflecting positive and safe client experiences.
Facilitator Expertise
Industry-Leading Experience: Satya's facilitators are among the most experienced in Oregon, with four team members having guided over 100 clients each.
-
Notable Facilitators:
Name
Clients Guided
Dr. Bonny Koeber
179
Dabney Finney
170
Andreas Met
161
Bern Haggard
117
Sector Benchmark: In Oregon's nascent industry, more than 50 client sessions is recognized as highly significant-Satya's facilitators far surpass this, ensuring depth of expertise and trauma-informed support.
Industry Collaboration and Advocacy
Psilocybin Alliance: Satya is a member of the newly established Psilocybin Alliance, a coalition advocating for inclusive, sustainable growth and best practices in the sector.
Policy Engagement: Andreas Met, Satya's COO, recently participated in a key Alliance meeting with Oregon Psilocybin Services leadership, emphasizing Satya's role in shaping effective, pro-operator regulatory frameworks.
Commitment to Access, Quality, and Innovation
Satya Therapeutics remains dedicated to:
Enhancing availability of safe, effective psilocybin services.
Maintaining industry-leading standards through expert facilitation.
Promoting affordability and inclusivity for all Oregonians interested in transformative psychedelic wellness.
For more information:
Visit: satyatherapeutics.com
Contact: andreas@satyatherapeutics.com
Satya Therapeutics - Dedicated to safe, affordable, and transformative psilocybin experiences guided by Oregon's most experienced facilitators.
SOURCE: SATYA INC.
View the original press release on ACCESS Newswire